KGTFY yields 5.63% · JNJ yields 2.13%● Live data
📍 KGTFY pulled ahead of the other in Year 1
Combined, KGTFY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGTFY + JNJ for your $10,000?
Krung Thai Bank Public Company Limited provides various commercial banking products and services. The company operates through three segments: Retail Banking, Wholesale Banking, and Treasury and Investment. It provides various retail banking products and services, including current, savings, and fixed deposit accounts; time and foreign currency deposits; personal and housing loans; debit, travel, cash and top up, and credit cards; investment services; travel, motor, and home asset insurance products; money transfer, payment and top up, foreign exchange, and overseas education services; and e-banking services. The company also offers SME loans for small and medium businesses; and international business loans. In addition, it provides corporate banking products and services comprising cash management services, such as collection, liquidity management, and transfer and payment services; fixed deposit and current accounts; foreign currency and term deposits; cards; Fx, interest rate, equity, commodity, and credit derivatives; financial advisory services related to merger and acquisition transactions; financial advisory, underwriting, and selling agent services for products offered through the equity capital markets; project finance advisory and feasibility study services, as well as e-banking services; and investment solutions, such as government and corporate bonds, structured notes, and investment units. The company provides its services through a network of branches in Thailand and various centers internationally. Krung Thai Bank Public Company Limited was founded in 1966 and is headquartered in Bangkok, Thailand.
Full KGTFY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.